Literature DB >> 27807147

Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Luis Furuya-Kanamori1, Thomas V Riley2,3, David L Paterson4, Niki F Foster2,3, Charlotte A Huber4, Stacey Hong2, Tiffany Harris-Brown4, Jenny Robson5, Archie C A Clements6.   

Abstract

Clostridium difficile infection (CDI) is becoming less exclusively a health care-associated CDI (HA-CDI). The incidence of community-associated CDI (CA-CDI) has increased over the past few decades. It has been postulated that asymptomatic toxigenic C. difficile (TCD)-colonized patients may play a role in the transfer of C. difficile between the hospital setting and the community. Thus, to investigate the relatedness of C. difficile across the hospital and community settings, we compared the characteristics of symptomatic and asymptomatic host patients and the pathogens from these patients in these two settings over a 3-year period. Two studies were simultaneously conducted; the first study enrolled symptomatic CDI patients from two tertiary care hospitals and the community in two Australian states, while the second study enrolled asymptomatic TCD-colonized patients from the same tertiary care hospitals. A total of 324 patients (96 with HA-CDI, 152 with CA-CDI, and 76 colonized with TCD) were enrolled. The predominant C. difficile ribotypes isolated in the hospital setting corresponded with those isolated in the community, as it was found that for 79% of the C. difficile isolates from hospitals, an isolate with a matching ribotype was isolated in the community, suggesting that transmission between these two settings is occurring. The toxigenic C. difficile strains causing symptomatic infection were similar to those causing asymptomatic infection, and patients exposed to antimicrobials prior to admission were more likely to develop a symptomatic infection (odds ratio, 2.94; 95% confidence interval, 1.20 to 7.14). Our findings suggest that the development of CDI symptoms in a setting without establishment of hospital epidemics with binary toxin-producing C. difficile strains may be driven mainly by host susceptibility and exposure to antimicrobials, rather than by C. difficile strain characteristics.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  Clostridium difficile; asymptomatic; community-acquired infections; health care-acquired infection; ribotyping

Mesh:

Year:  2016        PMID: 27807147      PMCID: PMC5228233          DOI: 10.1128/JCM.01779-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

2.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

3.  Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244.

Authors:  Charlotte A Huber; Lisa Hall; Nikki F Foster; Mareeka Gray; Michelle Allen; Leisha J Richardson; Jennifer Robson; Renu Vohra; Sanmarie Schlebusch; Narelle George; Graeme R Nimmo; Thomas V Riley; David L Paterson
Journal:  Commun Dis Intell Q Rep       Date:  2014-12-31

4.  Regarding "Clostridium difficile ribotype does not predict severe infection".

Authors:  A Sarah Walker; David W Eyre; Derrick W Crook; Mark H Wilcox; Tim E A Peto
Journal:  Clin Infect Dis       Date:  2013-02-18       Impact factor: 9.079

Review 5.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.

Authors:  Claudia Slimings; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2013-12-08       Impact factor: 5.790

6.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

7.  Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter.

Authors:  Daniel R Knight; Sara Thean; Papanin Putsathit; Stan Fenwick; Thomas V Riley
Journal:  Appl Environ Microbiol       Date:  2013-02-08       Impact factor: 4.792

8.  A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Authors:  Y Chen; K Glass; B Liu; T V Riley; R Korda; M D Kirk
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

9.  Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; Rosalind M Harding; Lily O'Connor; David Griffiths; Ali Vaughan; John Finney; Mark H Wilcox; Derrick W Crook; Tim E A Peto
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

10.  Clostridium difficile in ready-to-eat salads, Scotland.

Authors:  Marwah M Bakri; Derek J Brown; John P Butcher; Alistair D Sutherland
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more
  8 in total

Review 1.  Primary Prevention of Clostridium difficile-Associated Diarrhea: Current Controversies and Future Tools.

Authors:  Zachary A Rubin; Elise M Martin; Paul Allyn
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

2.  Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.

Authors:  Asiimwe Nicholas; Yu Kyung Kim; Won-Kil Lee; Gati Noble Selasi; Seok Hyeon Na; Hyo Il Kwon; Yoo Jeong Kim; Hae Sook Lee; Kyung Eun Song; Jeong Hwan Shin; Je Chul Lee
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

3.  New York City House Mice (Mus musculus) as Potential Reservoirs for Pathogenic Bacteria and Antimicrobial Resistance Determinants.

Authors:  Simon H Williams; Xiaoyu Che; Ashley Paulick; Cheng Guo; Bohyun Lee; Dorothy Muller; Anne-Catrin Uhlemann; Franklin D Lowy; Robert M Corrigan; W Ian Lipkin
Journal:  mBio       Date:  2018-04-17       Impact factor: 7.867

Review 4.  Clostridium difficile colitis and zoonotic origins-a narrative review.

Authors:  Alexander W W Brown; Robert B Wilson
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-06-28

Review 5.  2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Authors:  Massimo Sartelli; Stefano Di Bella; Lynne V McFarland; Sahil Khanna; Luis Furuya-Kanamori; Nadir Abuzeid; Fikri M Abu-Zidan; Luca Ansaloni; Goran Augustin; Miklosh Bala; Offir Ben-Ishay; Walter L Biffl; Stephen M Brecher; Adrián Camacho-Ortiz; Miguel A Caínzos; Shirley Chan; Jill R Cherry-Bukowiec; Jesse Clanton; Federico Coccolini; Maria E Cocuz; Raul Coimbra; Francesco Cortese; Yunfeng Cui; Jacek Czepiel; Zaza Demetrashvili; Isidoro Di Carlo; Salomone Di Saverio; Irina M Dumitru; Christian Eckmann; Edward H Eiland; Joseph D Forrester; Gustavo P Fraga; Jean L Frossard; Donald E Fry; Rita Galeiras; Wagih Ghnnam; Carlos A Gomes; Ewen A Griffiths; Xavier Guirao; Mohamed H Ahmed; Torsten Herzog; Jae Il Kim; Tariq Iqbal; Arda Isik; Kamal M F Itani; Francesco M Labricciosa; Yeong Y Lee; Paul Juang; Aleksandar Karamarkovic; Peter K Kim; Yoram Kluger; Ari Leppaniemi; Varut Lohsiriwat; Gustavo M Machain; Sanjay Marwah; John E Mazuski; Gokhan Metan; Ernest E Moore; Frederick A Moore; Carlos A Ordoñez; Leonardo Pagani; Nicola Petrosillo; Francisco Portela; Kemal Rasa; Miran Rems; Boris E Sakakushev; Helmut Segovia-Lohse; Gabriele Sganga; Vishal G Shelat; Patrizia Spigaglia; Pierre Tattevin; Cristian Tranà; Libor Urbánek; Jan Ulrych; Pierluigi Viale; Gian L Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-02-28       Impact factor: 5.469

Review 6.  Novel and emerging sources of Clostridioides difficile infection.

Authors:  Nicholas A Turner; Becky A Smith; Sarah S Lewis
Journal:  PLoS Pathog       Date:  2019-12-19       Impact factor: 6.823

7.  Biological characteristics associated with virulence in Clostridioides difficile ribotype 002 in Hong Kong.

Authors:  Ka Yi Kong; Thomas N Y Kwong; Hung Chan; Kristine Wong; Samuel S Y Wong; Anu P Chaparala; Raphael C Y Chan; Lin Zhang; Joseph J Y Sung; Jun Yu; Peter M Hawkey; Margaret Ip; William K K Wu; Sunny H Wong
Journal:  Emerg Microbes Infect       Date:  2020-03-17       Impact factor: 7.163

8.  High prevalence of Clostridiodes diffiicle PCR ribotypes 001 and 126 in Iran.

Authors:  Akram Baghani; Alireza Mesdaghinia; Ed J Kuijper; Amir Aliramezani; Malihe Talebi; Masoumeh Douraghi
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.